Björn Steffen
5PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.Julian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch
|Mar 23, 2024
Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.Thomas Burmeister, Aeint-Steffen Ströh, Britta Kehden
|Oct 13, 2023
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia.Jan-Niklas Eckardt, Sebastian Stasik, Christoph Röllig
|Sep 07, 2023
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.Jan-Niklas Eckardt, Marius Bill, Christian Rausch
|Aug 04, 2023
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.Julius C Enßle, Sebastian Wolf, Sebastian Scheich
Pageof 1
Frequent Collaborators
4 joint publications
Christoph Schliemann
4 joint publications
Stefan W Krause
4 joint publications
Maher Hanoun
4 joint publications
Claudia D Baldus
3 joint publications
Carsten Müller-Tidow
3 joint publications
Christoph Röllig
2 joint publications
Andreas Burchert
2 joint publications
Hubert Serve
2 joint publications
Jan-Niklas Eckardt
2 joint publications
Karsten Spiekermann
